Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2014 Mar 15;7(4):1293–1298.

Clarifying the nomenclature of intervertebral disc degeneration and displacement: from bench to bedside

Hai-Qiang Wang 1, Dino Samartzis 2
PMCID: PMC4014210  PMID: 24817926

Abstract

As a significant determinant of low back pain, intervertebral disc degeneration (IDD) has attracted more and more attention of both investigators and physicians. Disc herniation, termed as intervertebral disc displacement, is amongst the most prevalent spinal diseases closely linked with IDD. Due to the same origins and similar pathophysiology, the ambiguity regarding the similarity and difference of IDD and intervertebral disc displacement thus remains. The aim of this study was to clarify the nomenclature of IDD and disc herniation in terms of molecular etiology, pathophysiology, nature history and clinical outcomes. Collectively, IDD is a type of multifaceted, progressive spinal disease with or without clinical symptoms as back pain, characterized by extracellular matrix and the integrity of NP and AF lost, fissures formation. Disc herniation (termed as intervertebral disc displacement) is a type of spinal disease based on IDD or not, with local pain and/or sciatica due to mechanical compression and autoimmune cascades upon the corresponding nerve roots. Clarifying the nomenclature of intervertebral disc degeneration and displacement has important implications both for investigators and for physicians.

Keywords: Nomenclature, intervertebral disc, degeneration, displacement

Introduction

Low back pain has an impact on 80% of the population with overwhelming health-care and socioeconomic burden globally [1]. There are numerous determinants of low back pain [2-4], the chief of which is intervertebral disc degeneration (IDD). During the past decade, studies addressing IDD intensified considerably in terms of both clinically and basically [5-7]. The basic studies of IDD can be divided into three major subsets, i.e, the etiology of IDD ranging from genetics [8,9], microRNAs (miRNAs) [10-13], molecular alterations to cellular function within the disc [14,15], stem cell repair strategies [16], artificial biomaterials mimic the natural hallmarks of the disc [17-20].

Despite more and more novel findings have been unraveled by the worldwide investigators, the nomenclature of IDD has not been well documented and clarified so far. On the other hand, disc herniation termed as intervertebral disc displacement, is amongst the most prevalent spinal diseases closely linked with IDD. Due to the same origins and similar pathophysiology, the ambiguity regarding the similarity and difference of IDD and intervertebral disc displacement thus remains.

Normal intervertebral disc and immune privilege

The intervertebral disc plays important roles in the support, durability and flexibility of the spine by acting as mechanical stress absorber and transmitter on the basis of its unique structural feature. The disc is composed of 3 distinct but interlinked subparts: the outer layer as annulus fibrosus (AF), the central core as nucleus pulposus (NP) and the cartilage endplates connecting the disc to the adjacent vertebral bodies.

The structure of cells and tissues conforms to the requirements of their function. Within the harsh environment of the disc, there are large amounts of extracellular matrix but small amounts of highly specialized cells [21]. AF cells are elongated and polarized [22] in support of concentric lamellae consisting of both type-I and type-II collagen; whereas NP cells in adults are small, rounded and chondrocyte-like in support of extracellular matrix rich in type-II collagen and proteoglycans [23]. As localized within a nest under electron microscopy or capsule under light microscopy, both NP cells and AF cells are phagocytic in terms of autophagy and clearance of extracellular matrix and apoptotic cells [23-26].

Increasing evidence indicates that intervertebral disc belongs to immune privileged sites, owing to its avascular feature as well as molecular basis, FasL expression of NP [27-32]. In parallel with the findings of local expression of FasL and Fas in human NP cells, we further demonstrate that FasL expression in NP cells contribute for the maintenance of the immune privilege of the disc by interacting with immunocytes and vascular endothelial cells via both bound and soluble FasL-Fas machinery [33-35].

Intervertebral disc degeneration

With disc degeneration, the increasingly lost NP proteoglycans leads to reduced hydrodynamic transfer of axial stresses to the outer AF. Concurrently, the integrity of the AF is despoiled with radial fissures. The endplates undergo an ossification process and further reduce the nutritional supply to the disc.

IDD is multifaceted, the etiology of which including genetics [9], mechanical loading [14,36,37], aberrant expression profiles of miRNAs [10,13] and other molecules, such as CK8, link-N [15,38]. Accumulating evidence based on the Twin Spine Study indicates that heredity plays a much bigger role than environmental factors [39]. It is noteworthy that small non-coding RNAs, miRNAs, attract more and more attention in a variety of physiologic and pathologic processes. miRNAs are key post-transcriptional regulators by interacting with 3’-UTRs of their repressed genes. We addressed the expression profiles of miRNAs in IDD and further demonstrated that miR-155 promotes Fas-mediated apoptosis in human IDD by targeting FADD and CASP3 [10]. Despite a few studies addressed several other miRNAs in IDD, including miR-10b [13], the upstream regulation of miRNAs and their interaction with cytokines remain elusive.

As for the classification of IDD, there are clinical and histological schemes. Clinically, MRI is the current gold standard to assess the integrity of the disc. According to Pfirrmann and Boos [40], IDD can be classified as Grade I to V. As IDD progresses, the patients might complain low back pain rather than sciatica; whereas histological classification is proposed on the basis of degenerative hallmarks, such as cell clusters, fissures extents and morphology of AF [41-43].

In 2012, IDD was introduced into the PubMed as a MeSH term with an OMIM code as 603932. However, the term has not been widely accepted and used in the literature. A variety of other terms have been used, including IVDD, DDD (degenerative disc disease), LDD (lumbar disc degeneration), IVD degeneration etc. Unifying the term and nomenclature might be critical for global investigators and physicians.

The nomenclature of intervertebral disc degeneration

Therefore, IDD is a type of multifaceted, progressive spinal disease with or without clinical symptoms as back pain, characterized by extracellular matrix and the integrity of NP and AF lost, fissures formation. Moreover, IDD can exist in any part of the spine, including the cervical and thoracic spine. The most frequent region with IDD is at C5/6 (men: 51.5%, women: 46%), T6/7 (men: 32.4%, women: 37.7%), and L4/5 (men: 69.1%, women: 75.8%) [44].

As IDD develops, there are several types of outcome. One is intervertebral disc displacement, or disc herniation with clinical symptoms as sciatica. The other might be the decreased disc height which eventually results in spontaneous fusion of the spinal level without clinical symptoms.

The nomenclature of intervertebral disc displacement

As a MeSH term, the intervertebral disc displacement indicates the NP protrudes through the surrounding AF. Due to the anatomic hallmarks of posterior longitudinal ligament [45] and the range of motion, disc herniation most frequently occurs in the lower lumbar region. Since the fissures in AF often develop in the posterolateral region [46], intervertebral disc displacement might protrude posterolaterally to the adjacent nerve roots in the epidural region, resulting in sciatica. In addition to the compressive factors derived from the protrusion contributing to sciatica, the exposure of the immune-privileged NP triggers an autoimmune response involving macrophages, neutrophiles, T cells and B cells as well as proinflammatory cytokines, including interleukins and TNF-alpha [47-51]. Early clinical trials using TNF-alpha antagonists have been proven as a promising treatment option [52]. Patients with long term of herniation history might complain of numbness and motor weakness due to the immune cascades [53] in the region.

It should be stressed that intervertebral disc displacement can derive not only from elder patients with considerably IDD, but also from adolescent patients with minimal IDD. Therefore, IDD and disc herniation are different but somewhat linked diseases. Patients with severe IDD complaining of low back pain usually undergo fusion from anterior approach; whereas patients with severe disc sequestration usually undergo posterior discectomy. The ambiguity regarding the nomenclature of these two disorders in the literature still remains. Future studies using disc specimens should clarify the disc derivation as IDD or intervertebral disc displacement to avoid conceptual confusion and misleading.

Summary

IDD is a type of multifaceted, progressive spinal disease with or without clinical symptoms as back pain, characterized by extracellular matrix and the integrity of NP and AF lost, fissures formation. Disc herniation (termed as intervertebral disc displacement) is a type of spinal disease based on IDD or not, with local pain and/or sciatica due to mechanical compression and autoimmune cascades upon the corresponding nerve roots (Table 1). Clarifying the nomenclature of intervertebral disc degeneration and displacement has important implications both for investigators and for physicians.

Table 1.

Intervertebral disc degeneration and disc herniation

Diseases Intervertebral disc degeneration Disc herniation
MeSH term Intervertebral disc degeneration Intervertebral disc displacement
OMIM 603932 intervertebral disc disease 603932 intervertebral disc disease
Onset Slow, progressive Acute or sub-acute
Etiology Multifaceted Nucleus pulposus protrusion
Pathophysiology Loss of integrity of the disc Mechanical compression and immune cascades upon affected nerve roots
Region Lower lumbar spine most frequently Lower lumbar spine most frequently
Natural history Progression to herniation Immune absorption
Or lost of disc height until fusion Or progression to sequestration
Classification MRI grading system Location based classification
Histological grading system Degree of protrusion based classification
Clinical symptoms Slight to moderate: no symptoms Local regional pain with sciatica
Severe: local regional pain without sciatica
Diagnosis Clinical symptoms and MRI Clinical symptoms and radiographic images
Treatment Slight to moderate: observation and physical exercises Slight to moderate: rest, traction and physical therapy
Severe: anterior fusion Severe: posterior discectomy

Acknowledgements

This work was supported by Chinese National Natural Science Foundation Grant (No. 81270028).

Disclosure of conflict of interest

None.

References

  • 1.Anderson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354:581–585. doi: 10.1016/S0140-6736(99)01312-4. [DOI] [PubMed] [Google Scholar]
  • 2.Heuch I, Hagen K, Zwart JA. Body mass index as a risk factor for developing chronic low back pain: a follow-up in the Nord-Trondelag Health Study. Spine (Phila Pa 1976) 2013;38:133–139. doi: 10.1097/BRS.0b013e3182647af2. [DOI] [PubMed] [Google Scholar]
  • 3.Karjalainen U, Paananen M, Okuloff A, Taimela S, Auvinen J, Mannikko M, Karppinen J. Role of environmental factors and history of low back pain in sciatica symptoms among Finnish adolescents. Spine (Phila Pa 1976) 2013;38:1105–1111. doi: 10.1097/BRS.0b013e318287fb3a. [DOI] [PubMed] [Google Scholar]
  • 4.Lee S, Nam CM, Yoon do H, Kim KN, Yi S, Shin DA, Ha Y. Association between low-back pain and lumbar spine bone density: a population-based cross-sectional study. J Neurosurg Spine. 2013;19:307–313. doi: 10.3171/2013.5.SPINE12473. [DOI] [PubMed] [Google Scholar]
  • 5.Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG. The molecular basis of intervertebral disc degeneration. Spine J. 2013;13:318–330. doi: 10.1016/j.spinee.2012.12.003. [DOI] [PubMed] [Google Scholar]
  • 6.Iatridis JC, Nicoll SB, Michalek AJ, Walter BA, Gupta MS. Role of biomechanics in intervertebral disc degeneration and regenerative therapies: what needs repairing in the disc and what are promising biomaterials for its repair? Spine J. 2013;13:243–262. doi: 10.1016/j.spinee.2012.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chiang YF, Chiang CJ, Yang CH, Zhong ZC, Chen CS, Cheng CK, Tsuang YH. Retaining intradiscal pressure after annulotomy by different annular suture techniques, and their biomechanical evaluations. Clin Biomech (Bristol, Avon) 2012;27:241–248. doi: 10.1016/j.clinbiomech.2011.09.008. [DOI] [PubMed] [Google Scholar]
  • 8.Eskola PJ, Lemmela S, Kjaer P, Solovieva S, Mannikko M, Tommerup N, Lind-Thomsen A, Husgafvel-Pursiainen K, Cheung KM, Chan D, Samartzis D, Karppinen J. Genetic association studies in lumbar disc degeneration: a systematic review. PLoS One. 2012;7:e49995. doi: 10.1371/journal.pone.0049995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Song YQ, Karasugi T, Cheung KM, Chiba K, Ho DW, Miyake A, Kao PY, Sze KL, Yee A, Takahashi A, Kawaguchi Y, Mikami Y, Matsumoto M, Togawa D, Kanayama M, Shi D, Dai J, Jiang Q, Wu C, Tian W, Wang N, Leong JC, Luk KK, Yip SP, Cherny SS, Wang J, Mundlos S, Kelempisioti A, Eskola PJ, Mannikko M, Makela P, Karppinen J, Jarvelin MR, O’Reilly PF, Kubo M, Kimura T, Kubo T, Toyama Y, Mizuta H, Cheah KS, Tsunoda T, Sham PC, Ikegawa S, Chan D. Lumbar disc degeneration is linked to a carbohydrate sulfotransferase 3 variant. J Clin Invest. 2013;123:4909–4917. doi: 10.1172/JCI69277. doi: 10.1172/JCI69277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis D, Jia LT, Wu SX, Huang J, Chen J, Luo ZJ. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol. 2011;225:232–242. doi: 10.1002/path.2931. [DOI] [PubMed] [Google Scholar]
  • 11.Zhao B, Yu Q, Li H, Guo X, He X. Characterization of microRNA expression profiles in patients with intervertebral disc degeneration. Int J Mol Med. 2014;33:43–50. doi: 10.3892/ijmm.2013.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ohrt-Nissen S, Dossing KB, Rossing M, Lajer C, Vikesa J, Nielsen FC, Friis-Hansen L, Dahl B. Characterization of miRNA expression in human degenerative lumbar disks. Connect Tissue Res. 2013;54:197–203. doi: 10.3109/03008207.2013.781594. [DOI] [PubMed] [Google Scholar]
  • 13.Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X, Qiu G. MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration. PLoS One. 2013;8:e83080. doi: 10.1371/journal.pone.0083080. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 14.Sun Z, Guo YS, Yan SJ, Wan ZY, Gao B, Wang L, Liu ZH, Gao Y, Samartzis D, Lan LF, Wang HQ, Luo ZJ. CK8 phosphorylation induced by compressive loads underlies the downregulation of CK8 in human disc degeneration by activating protein kinase C. Lab Invest. 2013;93:1323–1330. doi: 10.1038/labinvest.2013.122. [DOI] [PubMed] [Google Scholar]
  • 15.Sun Z, Wang HQ, Liu ZH, Chang L, Chen YF, Zhang YZ, Zhang WL, Gao Y, Wan ZY, Che L, Liu X, Samartzis D, Luo ZJ. Down-regulated CK8 expression in human intervertebral disc degeneration. Int J Med Sci. 2013;10:948–956. doi: 10.7150/ijms.5642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sun Z, Liu ZH, Zhao XH, Sun L, Chen YF, Zhang WL, Gao Y, Zhang YZ, Wan ZY, Samartzis D, Wang HQ, Luo ZJ. Impact of direct cell co-cultures on human adipose-derived stromal cells and nucleus pulposus cells. J Orthop Res. 2013;31:1804–1813. doi: 10.1002/jor.22439. [DOI] [PubMed] [Google Scholar]
  • 17.Chan LK, Leung VY, Tam V, Lu WW, Sze KY, Cheung KM. Decellularized bovine intervertebral disc as a natural scaffold for xenogenic cell studies. Acta Biomater. 2013;9:5262–5272. doi: 10.1016/j.actbio.2012.09.005. [DOI] [PubMed] [Google Scholar]
  • 18.Frith JE, Cameron AR, Menzies DJ, Ghosh P, Whitehead DL, Gronthos S, Zannettino AC, Cooper-White JJ. An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. Biomaterials. 2013;34:9430–9440. doi: 10.1016/j.biomaterials.2013.08.072. [DOI] [PubMed] [Google Scholar]
  • 19.Frith JE, Menzies DJ, Cameron AR, Ghosh P, Whitehead DL, Gronthos S, Zannettino AC, Cooper-White JJ. Effects of bound versus soluble pentosan polysulphate in PEG/HA-based hydrogels tailored for intervertebral disc regeneration. Biomaterials. 2014;35:1150–1162. doi: 10.1016/j.biomaterials.2013.10.056. [DOI] [PubMed] [Google Scholar]
  • 20.Milani AH, Freemont AJ, Hoyland JA, Adlam DJ, Saunders BR. Injectable doubly cross-linked microgels for improving the mechanical properties of degenerated intervertebral discs. Biomacromolecules. 2012;13:2793–2801. doi: 10.1021/bm3007727. [DOI] [PubMed] [Google Scholar]
  • 21.Roberts S, Evans H, Trivedi J, Menage J. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am. 2006;88:10–14. doi: 10.2106/JBJS.F.00019. [DOI] [PubMed] [Google Scholar]
  • 22.Gruber HE, Ingram J, Hoelscher GL, Norton HJ, Hanley EN Jr. Cell polarity in the anulus of the human intervertebral disc: morphologic, immunocytochemical, and molecular evidence. Spine (Phila Pa 1976) 2007;32:1287–1294. doi: 10.1097/BRS.0b013e31805931d8. [DOI] [PubMed] [Google Scholar]
  • 23.Chen YF, Zhang YZ, Zhang WL, Luan GN, Liu ZH, Gao Y, Wan ZY, Sun Z, Zhu S, Samartzis D, Wang CM, Wang HQ, Luo ZJ. Insights into the hallmarks of human nucleus pulposus cells with particular reference to cell viability, phagocytic potential and long process formation. Int J Med Sci. 2013;10:1805–1816. doi: 10.7150/ijms.6530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nerlich AG, Weiler C, Zipperer J, Narozny M, Boos N. Immunolocalization of phagocytic cells in normal and degenerated intervertebral discs. Spine (Phila Pa 1976) 2002;27:2484–2490. doi: 10.1097/00007632-200211150-00012. [DOI] [PubMed] [Google Scholar]
  • 25.Jones P, Gardner L, Menage J, Williams G, Roberts S. Intervertebral disc cells as competent phagocytes in vitro: implications for cell death in disc degeneration. Arthritis Res Ther. 2008;10:R86. doi: 10.1186/ar2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ma KG, Shao ZW, Yang SH, Wang J, Wang BC, Xiong LM, Wu Q, Chen SF. Autophagy is activated in compression-induced cell degeneration and is mediated by reactive oxygen species in nucleus pulposus cells exposed to compression. Osteoarthritis Cartilage. 2013;21:2030–2038. doi: 10.1016/j.joca.2013.10.002. [DOI] [PubMed] [Google Scholar]
  • 27.Kim KW, Kim YS, Ha KY, Woo YK, Park JB, Park WS, An HS. An autocrine or paracrine Fas-mediated counterattack: a potential mechanism for apoptosis of notochordal cells in intact rat nucleus pulposus. Spine (Phila Pa 1976) 2005;30:1247–1251. doi: 10.1097/01.brs.0000164256.72241.75. [DOI] [PubMed] [Google Scholar]
  • 28.Park JB, Chang H, Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 2001;26:618–621. doi: 10.1097/00007632-200103150-00011. [DOI] [PubMed] [Google Scholar]
  • 29.Wang J, Tang T, Yang H, Yao X, Chen L, Liu W, Li T. The expression of Fas ligand on normal and stabbed-disc cells in a rabbit model of intervertebral disc degeneration: a possible pathogenesis. J Neurosurg Spine. 2007;6:425–430. doi: 10.3171/spi.2007.6.5.425. [DOI] [PubMed] [Google Scholar]
  • 30.Park JB, Kim KW, Han CW, Chang H. Expression of Fas receptor on disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 2001;26:142–146. doi: 10.1097/00007632-200101150-00006. [DOI] [PubMed] [Google Scholar]
  • 31.Takada T, Nishida K, Doita M, Kurosaka M. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine (Phila Pa 1976) 2002;27:1526–1530. doi: 10.1097/00007632-200207150-00009. [DOI] [PubMed] [Google Scholar]
  • 32.Kaneyama S, Nishida K, Takada T, Suzuki T, Shimomura T, Maeno K, Kurosaka M, Doita M. Fas ligand expression on human nucleus pulposus cells decreases with disc degeneration processes. J Orthop Sci. 2008;13:130–135. doi: 10.1007/s00776-007-1204-4. [DOI] [PubMed] [Google Scholar]
  • 33.Sun Z, Wan ZY, Liu ZH, Guo YS, Yin JB, Duan CG, Gao Y, Li T, Wang HQ, Luo ZJ. Expression of soluble Fas and soluble FasL in human nucleus pulposus cells. Int J Clin Exp Pathol. 2013;6:1567–1573. [PMC free article] [PubMed] [Google Scholar]
  • 34.Liu ZH, Sun Z, Wang HQ, Ge J, Jiang TS, Chen YF, Ma Y, Wang C, Hu S, Samartzis D, Luo ZJ. FasL expression on human nucleus pulposus cells contributes to the immune privilege of intervertebral disc by interacting with immunocytes. Int J Med Sci. 2013;10:1053–1060. doi: 10.7150/ijms.6223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sun Z, Wan ZY, Guo YS, Wang HQ, Luo ZJ. FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells. Int J Clin Exp Pathol. 2013;6:2376–2385. [PMC free article] [PubMed] [Google Scholar]
  • 36.Huang M, Wang HQ, Zhang Q, Yan XD, Hao M, Luo ZJ. Alterations of ADAMTSs and TIMP-3 in human nucleus pulposus cells subjected to compressive load: Implications in the pathogenesis of human intervertebral disc degeneration. J Orthop Res. 2012;30:267–273. doi: 10.1002/jor.21507. [DOI] [PubMed] [Google Scholar]
  • 37.Gilbert HT, Nagra NS, Freemont AJ, Millward-Sadler SJ, Hoyland JA. Integrin - dependent mechanotransduction in mechanically stimulated human annulus fibrosus cells: evidence for an alternative mechanotransduction pathway operating with degeneration. PLoS One. 2013;8:e72994. doi: 10.1371/journal.pone.0072994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Gawri R, Antoniou J, Ouellet J, Awwad W, Steffen T, Roughley P, Haglund L, Mwale F. Best paper NASS 2013: link-N can stimulate proteoglycan synthesis in the degenerated human intervertebral discs. Eur Cell Mater. 2013;26:107–119. doi: 10.22203/ecm.v026a08. discussion 119. [DOI] [PubMed] [Google Scholar]
  • 39.Battie MC, Videman T. Lumbar disc degeneration: epidemiology and genetics. J Bone Joint Surg Am. 2006;88(Suppl 2):3–9. doi: 10.2106/JBJS.E.01313. [DOI] [PubMed] [Google Scholar]
  • 40.Pfirrmann CWA, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 2001;26:1873–1878. doi: 10.1097/00007632-200109010-00011. [DOI] [PubMed] [Google Scholar]
  • 41.Rutges JP, Duit RA, Kummer JA, Bekkers JE, Oner FC, Castelein RM, Dhert WJ, Creemers LB. A validated new histological classification for intervertebral disc degeneration. Osteoarthritis Cartilage. 2013;21:2039–2047. doi: 10.1016/j.joca.2013.10.001. [DOI] [PubMed] [Google Scholar]
  • 42.Gries NC, Berlemann U, Moore RJ, Vernon-Roberts B. Early histologic changes in lower lumbar discs and facet joints and their correlation. Eur Spine J. 2000;9:23–29. doi: 10.1007/s005860050004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yu S, Haughton VM, Sether LA, Ho KC, Wagner M. Criteria for classifying normal and degenerated lumbar intervertebral disks. Radiology. 1989;170:523–526. doi: 10.1148/radiology.170.2.2911680. [DOI] [PubMed] [Google Scholar]
  • 44.Teraguchi M, Yoshimura N, Hashizume H, Muraki S, Yamada H, Minamide A, Oka H, Ishimoto Y, Nagata K, Kagotani R, Takiguchi N, Akune T, Kawaguchi H, Nakamura K, Yoshida M. Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population-based cohort: the Wakayama Spine Study. Osteoarthritis Cartilage. 2013;22:104–10. doi: 10.1016/j.joca.2013.10.019. [DOI] [PubMed] [Google Scholar]
  • 45.Bertram C, Prescher A, Furderer S, Eysel P. [Attachment points of the posterior longitudinal ligament and their importance for thoracic and lumbar spine fractures] . Orthopade. 2003;32:848–851. doi: 10.1007/s00132-003-0529-8. [DOI] [PubMed] [Google Scholar]
  • 46.Guterl CC, See EY, Blanquer SB, Pandit A, Ferguson SJ, Benneker LM, Grijpma DW, Sakai D, Eglin D, Alini M, Iatridis JC, Grad S. Challenges and strategies in the repair of ruptured annulus fibrosus. Eur Cell Mater. 2013;25:1–21. doi: 10.22203/ecm.v025a01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Geiss A, Larsson K, Rydevik B, Takahashi I, Olmarker K. Autoimmune Properties of Nucleus Pulposus: An Experimental Study in Pigs. Spine (Phila Pa 1976) 2007;32:168–173. doi: 10.1097/01.brs.0000251651.61844.2d. [DOI] [PubMed] [Google Scholar]
  • 48.Burke JG, Watson RWG, Conhyea D, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Human Nucleus Pulposis Can Respond to a Pro-inflammatory Stimulus. Spine. 2003;28:2685–2693. doi: 10.1097/01.BRS.0000103341.45133.F3. [DOI] [PubMed] [Google Scholar]
  • 49.Gabr MA, Jing L, Helbling AR, Sinclair SM, Allen KD, Shamji MF, Richardson WJ, Fitch RD, Setton LA, Chen J. Interleukin-17 synergizes with IFNgamma or TNFalpha to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res. 2011;29:1–7. doi: 10.1002/jor.21206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Habtemariam AMD, Virri JMS, Grönblad MMDP, Holm SP, Kaigle AP, Karaharju EMDP. Inflammatory Cells in Full-Thickness Anulus Injury in Pigs: An Experimental Disc Herniation Animal Model. Spine. 1998;23:524–529. doi: 10.1097/00007632-199803010-00002. [DOI] [PubMed] [Google Scholar]
  • 51.Grönblad M, Virri J, Seitsalo S, Habtemariam A, Karaharju E. Inflammatory Cells, Motor Weakness, and Straight Leg Raising in Transligamentous Disc Herniations. Spine. 2000;25:2803–2807. doi: 10.1097/00007632-200011010-00013. [DOI] [PubMed] [Google Scholar]
  • 52.Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllönen E, Lindgren KA, Rantanen P, Tervonen O, Niinimäki J, Seitsalo S, Hurri H. Tumor necrosis factor-[alpha] monoclonal antibody, infliximab, used to manage severe sciatica. Spine (Phila Pa 1976) 2003;28:750–753. [PubMed] [Google Scholar]
  • 53.Sun Z, Zhang M, Zhao XH, Liu ZH, Gao Y, Samartzis D, Wang HQ, Luo ZJ. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013;6:1009–1014. [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES